129 related articles for article (PubMed ID: 9329027)
1. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7.
Nakano S; Matsukado K; Black KL
Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
4. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
J Neurooncol; 1997 Sep; 34(2):131-8. PubMed ID: 9210059
[TBL] [Abstract][Full Text] [Related]
5. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
7. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M
J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
9. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
Acta Neurochir Suppl; 1997; 70():159-61. PubMed ID: 9416308
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
Inamura T; Black KL
J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
[TBL] [Abstract][Full Text] [Related]
11. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
13. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
14. Modified immunoregulation associated with interferon-gamma treatment of rat glioma.
Oshiro S; Liu Y; Fukushima T; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):359-66. PubMed ID: 11428516
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and modified immunoregulation associated with IFN-gamma treatment of RG2 gliomas.
Oshiro S; Fukushima T; Tomonaga M; Black KL
Anticancer Res; 1999; 19(6B):5029-36. PubMed ID: 10697506
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
Sugita M; Hunt GE; Liu Y; Black KL
Neurol Res; 1998 Sep; 20(6):559-63. PubMed ID: 9713849
[TBL] [Abstract][Full Text] [Related]
17. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
18. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
19. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model.
Britz GW; Ghatan S; Spence AM; Berger MS
J Neurooncol; 2002 Feb; 56(3):227-32. PubMed ID: 12061728
[TBL] [Abstract][Full Text] [Related]
20. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
